Found: 19
Select item for more details and to access through your institution.
Memory B cell–guided extended interval dosing of ocrelizumab in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 857, doi. 10.1177/13524585241250199
- By:
- Publication type:
- Article
Late-onset multiple sclerosis from a different angle.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 765, doi. 10.1177/13524585241249901
- By:
- Publication type:
- Article
Artificial intelligence applied to MRI data to tackle key challenges in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 767, doi. 10.1177/13524585241249422
- By:
- Publication type:
- Article
Depression is a core symptom of multiple sclerosis: Yes.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 785, doi. 10.1177/13524585241249564
- By:
- Publication type:
- Article
Meaningful cognitive change for the Minimal Assessment of Cognitive Function in Multiple Sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 868, doi. 10.1177/13524585241249084
- By:
- Publication type:
- Article
The association of comorbidities with sleep quality among Australians with multiple sclerosis: Insights from the Australian Multiple Sclerosis Longitudinal Study.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 877, doi. 10.1177/13524585241248278
- By:
- Publication type:
- Article
Improving explanation of motor disability with diffusion-based graph metrics at onset of the first demyelinating event.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 800, doi. 10.1177/13524585241247785
- By:
- Publication type:
- Article
Extended interval dosing with ocrelizumab in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 847, doi. 10.1177/13524585241245296
- By:
- Publication type:
- Article
Depression is a core symptom of multiple sclerosis: No.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 787, doi. 10.1177/13524585241245653
- By:
- Publication type:
- Article
Depression is a core symptom of multiple sclerosis: Commentary.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 788, doi. 10.1177/13524585241245637
- By:
- Publication type:
- Article
Prevalence and incidence of multiple sclerosis in Turkey: A nationwide epidemiologic study.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 790, doi. 10.1177/13524585241245318
- By:
- Publication type:
- Article
Retinal small vessel pathology is associated with disease burden in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 812, doi. 10.1177/13524585241247775
- By:
- Publication type:
- Article
Therapeutic lag: Is treatment effect delayed in progressive MS?
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 843, doi. 10.1177/13524585241244751
- By:
- Publication type:
- Article
Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 833, doi. 10.1177/13524585241242050
- By:
- Publication type:
- Article
Prediction of disease activity and treatment failure in relapsing–remitting MS patients initiating daily oral DMTs.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 820, doi. 10.1177/13524585241240653
- By:
- Publication type:
- Article
Psoriasisform dermatitis following anti-CD20 therapies: Immunologic lessons and management dilemmas.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 897, doi. 10.1177/13524585241232283
- By:
- Publication type:
- Article
Psoriasiform dermatitis following ocrelizumab in relapsing-remitting multiple sclerosis: Case report and literature review.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 893, doi. 10.1177/13524585241232277
- By:
- Publication type:
- Article
The impact of social distancing measures on anti–JC virus serostatus changes before and during the COVID-19 pandemic in US patients with multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 888, doi. 10.1177/13524585241232274
- By:
- Publication type:
- Article
Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society.
- Published in:
- Multiple Sclerosis Journal, 2024, v. 30, n. 7, p. 899, doi. 10.1177/13524585231223880
- By:
- Publication type:
- Article